Multi-Institutional survey on the value of lymphadenectomy in endometrial carcinoma in Germany;Multizentrische umfrage zum stellenwert der lymphonodektomie beim endometriumkarzinom in Deutschland

Gynakologisch-geburtshilfliche Rundschau

Volumn 43, Issue 2, 2003, Pages 104-110

  Sehouli, Jalid ^a   Camara, Oumar ^b   Stengel, Dirk ^d   Köhler, Günter ^c   Lichtenegger, Werner ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c Klin fur Frauenheilkunde/G   (Germany)

^d Klin Frauenheilkunde/Geburtshilfe ^*

Author keywords

Endometrial cancer; Lymphadenectomy; Management

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; ENDOMETRIUM CARCINOMA; GERMANY; GYNECOLOGY; HOSPITAL PATIENT; HUMAN; LYMPH NODE DISSECTION; MEDICAL DECISION MAKING; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; QUESTIONNAIRE; UNIVERSITY HOSPITAL;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT;

EID: 0037242303     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069163     Document Type: Article

References (46)

1. Pecorelli S: FIGO annual report on the result of treatment in gynaecological cancer -23rd ed. J Epidemiol Biostat 1998;3:1-168.
2. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R: Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Pathol 1982;6:93.
3. Piver MS, Lele SB, Barlow JJ, Blumenson L: Para-aortic lymph node evaluation in stage I endometrial carcinoma. Obstet Gynecol 1982;59:97.
4. Lewis BV, Chapman PA: Screening for endometrial carcinoma using a negative pressure intrauterine 'jet wash'. Arch Geschwulstforsch 1977;47:314.
5. Silverberg SG, DeGiorgi LS: Histopathologic analysis of reoperative radiation therapy in endometrial carcinoma. Am J Obstet Gynecol 1974;119:698-704.
6. Hanson MB, van Nagell JR Jr, Powell DE, Donaldson ES, Gallion H, Merhige M, Pavlik EJ: The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985;55:1753.
7. Sivridis E, Buckley CH, Fox H: The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br J Obstet Gynecol 1987;94:991.
8. Gal D, Recio FO, Zamurovic D, Tancer ML: Lymph vascular space involvement - A prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 1991;42:142-145.
9. Creasman WT, Disaia PJ, Blessing J, Wilkinson RH Jr, Johnston W, Weed JC Jr: Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981;141:921.
10. Lurain JR, Rumsey NK, Schink JC, Wallemark CB, Chmiel JS: Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1989;74:175.
11. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT: The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74:775-780.
12. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA: Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825.
13. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB: Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group study. Cancer 1987;60(suppl):2035-2041.
14. Sant Cassia LJ, Weppelmann B, Shingleton H, Soong SJ, Hatch K, Salter MM: Management of early endometrial carcinoma. Gynecol Oncol 1989;35:362.
15. Wilson TO, Podratz KC, Gaffey TA, Malkasian GD Jr, O'Brien PC, Naessens JM: Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990;162:418.
16. Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS: Endometrial adenocarcinoma histologic subtypes: Clinical and pathologic profile. Gynecol Oncol 1989;32:288-291.
17. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991; 40:55-65.
18. Chen SS: Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri: No recurrence with only primary surgery. Cancer 1989;63:1843-1845.
19. Announcements: FIGO stages: 1988 revision. Gynecol Oncol 1989;35:125-126.
20. Interdisziplinäre Kurzgefasste Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. Endometriumkarzinom. Kurzgefasste Interdisziplinäre Leitlinien 2000, B22, pp 287 ff.
21. Bremond A, Bataillard A, Thomas L, Achard JL, Fervers B, Fondrinier E, Lansac J, Bailly C, Hoffstetter S, Basuyau JP, d'Anjou J, Descamps P, Farsi F, Guastalla JP, Laffargue F, Rodier JF, Vincent P, Pigneux J: Fédération nationale des centres de lutte contre le cancer (Standards, options and recommendations for the surgical management of carcinoma of the endometrium). Bull Cancer 2001;88:181-198.
22. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A: An analysis of approaches to the management of endometrial cancer in North America: A CTF study. Gynecol Oncol 1998;68:274-279.
23. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A: An analysis of approaches to the treatment of endometrial cancer in western Europe: A CTF study. Eur J Cancer 1995;31A:1993-1997.
24. Burghardt E, Winter R, Tamussino K, Pickel H, Lahousen M, Haas J, Girardi F, Ebner F, Hackl A, Pfister H: Diagnosis and surgical treatment of cervical cancer. Crit Rev Oncol Hematol 1994;17:181-231.
25. Mariani A, Webb MJ, Keeney GL, Podratz KC: Routes of lymphatic spread: A study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 2001;81:100-104.
26. Henriksen E: The lymphatic dissemination in endometrial carcinoma: A study of 188 necropsies. Am J Obstet Gynecol 1975;123:570-576.
27. McMeekin DS, Lashbrook D, Gold M, Scribner DR, Kamelle S, Tillmanns TD, Mannel R: Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 2001;82:375-379.
28. Girardi F, Petru E, Heydarfadai M, Haas J, Winter R: Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993;49:177-180.
29. Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DM: Staging laparotomy for endometrial carcinoma: Assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995;58:189-193.
30. Trimble EL, Kosary C, Park RC: Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998;71:340-343.
31. Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, Yun HJ: Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998;70:165-171.
32. Orr JW, Orr PF, Taylor PT: Surgical staging endometrial cancer. Clin Obstet Gynecol 1996;39:656-669.
33. COSA-NZ-IK Endometrial Cancer Study Groups: Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 1996;6:102-107.
34. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F 3rd, Conner W: Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.
35. Rose PG, Cha SD, Tak WK: Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. Int Radiat Oncol Biol Phys 1992;24:229-233.
36. Podratz KC, Mariani A, Webb MJ: Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 1998;70:163-164.
37. Aalders J, Abeler V, Kolstad P, Onsrud M: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-427.
38. Larson DM, Broste SK, Krawisz BR: Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 1998;91:355-359.
39. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Hobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M: Randomised trial of surgery and postoperative radiation therapy versus surgery alone for patients with stage I endometrial carcinoma. Lancet 2000;355:1404-1411.
40. Wolfson AH, Sightler SE, Markoe AM, Schwade JG, Averette HE, Ganjei P, Hilsenbeck SG: The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992;45:142-146.
41. Robert JA, Brunetto VL, Keys HM: A phase III randomized study of surgery vs. surgery plus adjuvant radiation in intermediate-risk endo-metrial adenocarcinoma (GOG No 99) (abstract 258). Gynecol Oncol 1998;68:135.
42. Thipgen JT, Blessing JA, Homesley HD: Phase III trial of doxorubicin +/- cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) study. Proc Am Soc Clin Oncol 1993;12:261.
43. Ball HG, Blessing JA, Lentz SS, Mutch DG: A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1996;62:278-281.
44. Onishi Y, Nakamura T, Yamamoto F, et al: Evaluation of paclitaxel in patients with endometrial cancer. Proc ASCO, 2001, vol 20, abstract 2509.
45. Chambers JT, Rutherford TJ, Schwartz P: A pilot study of topotecan for the treatment of serous endometrial cancer. Proc ASCO, New Orleans, 2001, vol 20, abstract 872.
46. Hoskins P, Swenerton K, Pike J: Carboplatin/paclitaxel ± irradiation for advanced or recurrent endometrial cancer. Proc ASCO, New Orleans, 2001, vol 20, abstract 820.